Clinical Trial Update: Dapagliflozin Effect on Rheumatic Mitral Stenosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dapagliflozin for rheumatic mitral stenosis in patients with rheumatic heart disease and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Stenosis
• Rheumatic Heart Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Universitas Sebelas Maret | Conditions: Rheumatic Heart Disease, Heart Failure | Phase 3 | Status: UNKNOWN